Company Overview and News

0
Economy Hub: Stephen Tindall - life after The Warehouse

2018-07-19 nzherald.co.nz
It's only as we're driving away from the interview at his small Tindall Foundation office in Takapuna that I realise I've forgotten to acknowledge that at any stage.
WHOSY WHGPF WHS

0
60 leading Kiwi CEOs commit to climate action

2018-07-11 nzherald.co.nz
Bosses of 60 companies that make up nearly half of New Zealand's greenhouse gas emissions have pledged to take a fresh stand on climate change.
CEN AIR ZNRGF WHGPF ZEL ANZFY COENY AIZ WHS COENF ZNZ WHOSY ANZLY CEN ANZFF

0
Warehouse restructure would affect 769 people nationally

2018-07-05 nzherald.co.nz
The Warehouse Group has told First Union that its latest restructure has nothing to do with economic savings.
WHOSY WHGPF WHS

0
Warehouses remain tight-lipped over worker losses

2018-07-04 nzherald.co.nz
It's still uncertain whether the Hastings and Napier Warehouses will be affected by job losses due to a major restructure.
WHOSY WHGPF WHS

1
The Warehouse proposes laying off 180 staff

2018-06-28 nbr.co.nz
Warehouse staff were told yesterday about a proposal to make about 180 store managers, team leaders and supervisors redundant.
WHOSY WHGPF WHS

1
The Warehouse to lay off 180 staff, union claims

2018-06-28 nbr.co.nz
The Warehouse will make about 180 store managers, team leaders and supervisors redundant, according to First Union's Dennis Maga.
WHOSY WHGPF WHS

1
Outdoor gear retailer Torpedo7 to open new stores despite falling operating margins

2018-05-28 nzherald.co.nz
Outdoor equipment retailer Torpedo7, once an online-only operation, is gearing up to open new stores despite shrinking operating margins.
WHOSY WHGPF WHS

1
Warehouse Group ditches single-use plastic bags

2018-05-17 nzherald.co.nz
The Warehouse Group is set to ditch all single-use plastic checkout bags and replace them with fully compostable bags.
WHOSY WHGPF WHS

10
NZX 50 charts record highs, led by Ryman, F&P Healthcare

2018-05-11 nzherald.co.nz
New Zealand's benchmark stock index rose to a fresh record, led by retirement village operator Ryman Healthcare and Fisher & Paykel Healthcare Corp, while Pushpay fell.
AIA WHOSY RHCGF AIA PPSHY RYHTY RYM WHGPF ACKDF AUKNY SML WHS

1
Retail magnates the Normans increase stake in 'bland' underperforming The Warehouse

2018-05-11 nzherald.co.nz
James Pascoe Group owners Anne and David Norman have lifted their stake in The Warehouse but analysts say it does not signal a takeover attempt - at least not yet.
WHOSY WHGPF WHS

1
Warehouse Group lifts third-quarter sales 2.6%

2018-05-10 nzherald.co.nz
Warehouse Group's third-quarter sales advanced 2.6 per cent as its Noel Leeming appliance and technology chain outperformed its other businesses.
WHOSY WHGPF WHS

1
Commerce Commission takes Noel Leeming to court for allegedly misleading consumers

2018-04-27 nbr.co.nz
RELATED AUDIO: Consumer CEO Sue Chetwin on extended warranties — are they worth it? (Mar, 2016)
WHOSY WHGPF WHS

1
Noel Leeming stores accused of misleading customers

2018-04-27 radionz.co.nz
Electronic goods retailer Noel Leeming has been charged with misleading customers at eight of its stores.
WHOSY WHGPF WHS

1
Noel Leeming charged by ComCom over misleading consumers

2018-04-27 nzherald.co.nz
"We're disappointed by the Commission's enforcement decision which came without the opportunity to investigate or discuss the complaints," a spokesperson for Noel Leeming said. "We take our compliance responsibilities seriously and we want to do the right thing by our customers. "As the matter is before the Court, we won't be making further comments."
WHOSY WHGPF WHS

1
Ethical fashion ranking: How New Zealand's largest retailers and brands fare

2018-04-17 nzherald.co.nz
An advocate for ethical fashion retail says top brands are not doing enough to protect workers in their international supply chains despite attempts being made.
WHOSY WHGPF WHS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...